OrgSyn Laboratory, Inc. (OSL) is a research and development company with a small scale manufacturing capability for custom synthesis, contract research and process development. It is geared towards providing services to the biotechnology, biopharmaceutical, pharmaceutical and specialty chemicals sectors. OrgSyn Laboratory is a well-equipped laboratory located in the Chicago Technology Park. The company is managed, operated and staffed by highly experienced process chemists with over a hundred years of experience in organic synthesis and pharmaceutical process research and development. Scientists at OrgSyn Laboratory are actively involved in developing drug candidates, starting as early as preclinical stage and taking them all way to NDA filing. These developments are done in collaboration with Biotech and Phrama companies in the USA Our niche is the synthesis and manufacture of complex organic compounds as advance intermediates and APIs under cGMP conditions. Our capabilities include the full range of synthesis from gram to multi-kilo scale. An integrated quality control and quality assurance program ensures the application of cGMP.

We will be the premier process development and manufacturing arm for pharmaceutical intermediates and APIs under cGMP conditions. Towards achieving these objectives, we provide excellent customer services and superior capabilities in specific manufacturing areas such as chiral synthesis, large-scale column chromatography, high vacuum distillation and reactions involving moisture sensitive organometallic reagents. Underlying all projects is a keen appreciation of the need for realistic delivery time estimates and economy of pricing. Our main focus is to support pharmaceuticals and biotechnology companies to accelerate the movement of products through process development and cGMP manufacturing with an absolute commitment to quality, speed and customer satisfaction. We are dedicated to developing long-term partnership that supports your objectives. We will anticipate and respond to your changing needs encountered in the course of pharmaceutical development.